1-3 of 3
Susan Arentsen-Peters
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Selective Inhibition of Class II HDAC Isoforms 4 and 5 Provides a Promising Therapeutic Intervention for MLL -Rearranged Acute Lymphoblastic Leukemia in Infants

Tamara C.A.I. Verbeek, Susan Arentsen-Peters, Patricia Garrido Castro, Sandra Pinhancos, Kirsten Vrenken, Aida Varela-Moreira, M. Emmy Dolman, Bianca Koopmans, Rob Pieters, Ronald W. Stam
Journal: Blood
Blood (2021) 138 (Supplement 1): 2206.
https://doi.org/10.1182/blood-2021-147164
Published: 2021
Journal Articles

A Novel Approach for Analyzing Gene Expression Profiles Defines Two Distinct Subgroups of t(4;11) Positive Infant Acute Lymphoblastic Leukemia Patients.

Ronald W. Stam, Stefan Bohlander, Renate Kirschner-Schwabe, Susan Arentsen-Peters, Rob Pieters, Theo Dingermann, Rolf Marschalek
Journal: Blood
Blood (2007) 110 (11): 4282.
https://doi.org/10.1182/blood.V110.11.4282.4282
Published: 2007
Journal Articles

Nucleophosmin Gene Mutations Identify a Favorable Risk Group in Childhood Acute Myeloid Leukemia with a Normal Karyotype.

Iris H. Hollink, Christian M. Zwaan, Marry M. van den Heuvel-Eibrink, Martin Zimmerman, Susan Arentsen-Peters, Rob Pieters, Jacqueline Cloos, Gertjan J. Kaspers, Siebold S. De Graaf, Ursula Creutzig, Dirk Reinhardt, Christian Thiede
Journal: Blood
Blood (2007) 110 (11): 366.
https://doi.org/10.1182/blood.V110.11.366.366
Published: 2007